Table 3.
Pharmacokinetic parameters of CBD oil (100 mg/kg) and CBD-NE (50 mg/kg) administered orally to rats
| Parameter | CBD oil (n = 4) | CBD-NE (n = 5) | p |
|---|---|---|---|
| Dose, mg/kg | 100 | 50 | |
| AUC0–24, mg h/L | 25.3±4.4 | 16.2±2.7 | |
| AUC0–24/dose, h kg/L | 0.253±0.044 | 0.324±0.053 | 0.409 |
| AUC0-∞, mg h/L | 26.7±4.5 | 22.4±4.3 | |
| AUC0-∞/dose, h kg/L | 0.272±0.045 | 0.448±0.087 | 0.172 |
| T1/2, h | 4.68±0.31 | 2.40±3.49 | 0.069 |
| CLtot/F, L/h/kg | 4.29±1.67 | 2.81±0.67 | 0.258 |
| Vdss/F, L/kg | 46.7±9.6 | 36.0±7.4 | 0.456 |
| Tmax, h | 8.00±0.00 | 2.40±0.46 | <0.001*** |
| Cmax, μg/mL | 2.72±0.37 | 3.23±0.80 | |
| Cmax/dose, kg/L | 0.0272±0.0037 | 0.0646±0.0159 | 0.103 |
| MRT, h | 10.8±0.4 | 15.10±3.7 | 0.356 |
Each value is expressed as mean ± SEM.
AUC, area under the concentration versus time curve; T1/2, terminal half-life; CLtot/F, total clearance; Vdss/F, volume of distribution; Cmax, maximum blood concentration; Tmax, time to reach Cmax; MRT, mean residence time.
p < 0.001 versus CBD oil.